1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225–
2. Terry,M.B. et al. (2002) Risk factors for advanced colorectal adenomas:
a pooled analysis. Cancer Epidemiol. Biomarkers Prev., 11, 622–629.
3. Huxley,R.R. et al. (2009) The impact of dietary and lifestyle risk factors on
risk of colorectal cancer: a quantitative overview of the epidemiological
evidence. Int. J. Cancer, 125, 171–180.
4. Lichtenstein,P. et al. (2000) Environmental and heritable factors in the
causation of cancer–analyses of cohorts of twins from Sweden, Denmark,
and Finland. N. Engl. J. Med., 343, 78–85.
5. Tenesa,A. et al. (2009) New insights into the aetiology of colorectal cancer
from genome-wide association studies. Nat. Rev. Genet., 10, 353–358.
6. Houlston,R.S. et al. (2010) Meta-analysis of three genome-wide associa-
tion studies identiﬁes susceptibility loci for colorectal cancer at 1q41,
3q26.2, 12q13.13 and 20q13.33. Nat. Genet., 42, 973–977.
7. Park,J.H. et al. (2010) Estimation of effect size distribution from genome-
wide association studies and implications for future discoveries. Nat.
Genet., 42, 570–575.
8. Botteri,E. et al. (2008) Cigarette smoking and adenomatous polyps: a meta-
analysis. Gastroenterology, 134, 388–395.
9. Giovannucci,E. et al. (1996) Tobacco, colorectal cancer, and adenomas:
a review of the evidence. J. Natl Cancer Inst., 88, 1717–1730.
10. Raimondi,S. et al. (2009) Gene-smoking interaction on colorectal adenoma
and cancer risk: review and meta-analysis. Mutat. Res, 670, 6–14.
11. Wood,R.D. et al. (2005) Human DNA repair genes, 2005. Mutat. Res., 577,
12. Kinzler,K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell,
13. Nielsen,M. et al. (2009) Analysis of MUTYH genotypes and colorectal
phenotypes in patients With MUTYH-associated polyposis. Gastroenterol-
ogy, 136, 471–476.
14. Berndt,S.I. et al. (2007) Genetic variation in base excision repair genes and
the prevalence of advanced colorectal adenoma. Cancer Res., 67, 1395–
15. Stern,M.C. et al. (2006) XRCC1, XRCC3, and XPD polymorphisms as
modiﬁers of the effect of smoking and alcohol on colorectal adenoma risk.
Cancer Epidemiol. Biomarkers Prev., 15, 2384–2390.
16. Skjelbred,C.F. et al. (2006) Polymorphisms of the XRCC1, XRCC3 and
XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian
cohort: a case control study. BMC Cancer, 6, 67.
17. Bigler,J. et al. (2005) DNA repair polymorphisms and risk of colorectal
adenomatous or hyperplastic polyps. Cancer Epidemiol. Biomarkers Prev.,
18. Mrkonjic,M. et al. (2010) Speciﬁc variants in the MLH1 gene region may
drive DNA methylation, loss of protein expression, and MSI-H colorectal
cancer. PLoS One, 5, e13314.
19. Raptis,S. et al. (2007) MLH1 -93G.A promoter polymorphism and the
risk of microsatellite-unstable colorectal cancer. J. Natl Cancer Inst., 99,
20. Samowitz,W.S. et al. (2008) The MLH1 -93 G.A promoter polymorphism
and genetic and epigenetic alterations in colon cancer. Genes Chromosomes
Cancer, 47, 835–844.
21. Campbell,P.T. et al. (2009) Mismatch repair polymorphisms and risk of
colon cancer, tumour microsatellite instability and interactions with life-
style factors. Gut, 58, 661–667.
22. Hayes,R.B. et al. (2005) Methods for etiologic and early marker investiga-
tions in the PLCO trial. Mutat. Res., 592, 147–154.
23. Prorok,P.C. et al. (2000) Design of the Prostate, Lung, Colorectal and
Ovarian (PLCO) Cancer Screening Trial. Control. Clin. Trials, 21, 273S–
24. Weissfeld,J.L. et al. (2005) Flexible sigmoidoscopy in the PLCO cancer
screening trial: results from the baseline screening examination of a ran-
domized trial. J. Natl Cancer Inst., 97, 989–997.
25. Carlson,C.S. et al. (2004) Selecting a maximally informative set of single-
nucleotide polymorphisms for association analyses using linkage disequi-
librium. Am. J. Hum. Genet., 74, 106–120.
26. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am. J. Hum. Genet., 81, 559–575.
27. Barrett,J.C. et al. (2005) Haploview: analysis and visualization of LD and
haplotype maps. Bioinformatics, 21, 263–265.
28. Schaid,D.J. et al. (2002) Score tests for association between traits and haplo-
types when linkage phase is ambiguous. Am.J.Hum.Genet., 70, 425–434.
29. Lynch,H.T. et al. (2009) Review of the Lynch syndrome: history, molecular
genetics, screening, differential diagnosis, and medicolegal ramiﬁcations.
Clin. Genet., 76, 1–18.
30. de la Chapelle,A. (2004) Genetic predisposition to colorectal cancer. Nat.
Rev. Cancer, 4, 769–780.
31. Foulkes,W.D. (2008) Inherited susceptibility to common cancers. N. Engl.
J. Med., 359, 2143–2153.
32. Tran,P.T. et al. (2004) EXO1-A multi-tasking eukaryotic nuclease. DNA
Repair (Amst.), 3, 1549–1559.
33. Wei,K. et al. (2003) Inactivation of Exonuclease 1 in mice results in DNA
mismatch repair defects, increased cancer susceptibility, and male and
female sterility. Genes Dev., 17, 603–614.
34. Liberti,S.E. et al. (2004) Is hEXO1 a cancer predisposing gene? Mol.
Cancer Res., 2, 427–432.
35. Ramensky,V. et al. (2002) Human non-synonymous SNPs: server and sur-
vey. Nucleic Acids Res., 30, 3894–3900.
36. Chang,J.S. et al. (2008) Pathway analysis of single-nucleotide polymor-
phisms potentially associated with glioblastoma multiforme susceptibility
using random forests. Cancer Epidemiol. Biomarkers Prev., 17, 1368–
37. Hsu,N.Y. et al. (2009) Lung cancer susceptibility and genetic polymor-
phisms of Exo1 gene in Taiwan. Anticancer Res., 29, 725–730.
38. Jin,G. et al. (2008) Potentially functional polymorphisms of EXO1 and risk
of lung cancer in a Chinese population: a case-control analysis. Lung Can-
cer, 60, 340–346.
39. Tsai,M.H. et al. (2009) Interaction of Exo1 genotypes and smoking habit in
oral cancer in Taiwan. Oral Oncol., 45, e90–e94.
40. Yamamoto,H. et al. (2005) Single nucleotide polymorphisms in the EXO1
gene and risk of colorectal cancer in a Japanese population. Carcinogene-
sis, 26, 411–416.
41. Yoshiya,G. et al. (2008) Inﬂuence of cancer-related gene polymorphisms
on clinicopathological features in colorectal cancer. J. Gastroenterol. Hep-
atol., 23, 948–953.
42. Zienolddiny,S. et al. (2006) Polymorphisms of DNA repair genes and risk
of non-small cell lung cancer. Carcinogenesis, 27, 560–567.
43. Haghighi,M.M. et al. (2010) Impact of EXO1 polymorphism in suscepti-
bility to colorectal cancer. Genet. Test. Mol. Biomarkers, 14, 649–652.
44. Wang,H.C. et al. (2009) Association of genetic polymorphisms of EXO1
gene with risk of breast cancer in Taiwan. Anticancer Res., 29, 3897–3901.
45. Ji,B.T. et al. (2006) Tobacco smoking and colorectal hyperplastic and
adenomatous polyps. Cancer Epidemiol. Biomarkers Prev., 15, 897–901.
46. Morrell,D. et al. (1986) Mortality and cancer incidence in 263 patients with
ataxia-telangiectasia. J. Natl Cancer Inst., 77, 89–92.
47. Thompson,D. et al. (2005) Cancer risks and mortality in heterozygous
ATM mutation carriers. J. Natl Cancer Inst., 97, 813–822.
48. Kweekel,D.M. et al. (2009) Explorative study to identify novel candidate
genes related to oxaliplatin efﬁcacy and toxicity using a DNA repair array.
Br. J. Cancer., 101, 357–362.
49. Webb,E.L. et al. (2006) Search for low penetrance alleles for colorectal
cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and
2707 controls with validation by kin-cohort analysis of 14 704 ﬁrst-degree
relatives. Hum. Mol. Genet., 15, 3263–3271.
50. Jones,J.S. et al. (2005) ATM polymorphism and hereditary nonpolyposis
colorectal cancer (HNPCC) age of onset (United States). Cancer Causes
Control, 16, 749–753.
51. Maillet,P. et al. (2000) A polymorphism in the ATM gene modulates the
penetrance of hereditary non-polyposis colorectal cancer. Int. J. Cancer, 88,
52. Concannon,P. et al. (2008) Variants in the ATM gene associated with a re-
duced risk of contralateral breast cancer. Cancer Res., 68, 6486–6491.
53. Jorgensen,E.D. et al. (2010) DNA damage response induced by exposure of
human lung adenocarcinoma cells to smoke from tobacco- and nicotine-
free cigarettes. Cell Cycle, 9, 2170–2176.
54. Liang,Z. et al. (2003) Identiﬁcation of benzo(a)pyrene diol epoxide-bind-
ing DNA fragments using DNA immunoprecipitation technique. Cancer
Res., 63, 1470–1474.
55. Jiang,Y. et al. (2007) Ataxia-telangiectasia mutated expression is associ-
ated with tobacco smoke exposure in esophageal cancer tissues and ben-
zo[a]pyrene diol epoxide in cell lines. Int. J. Cancer, 120, 91–95.
56. Pinsky,P.F. et al. (2007) Evidence of a healthy volunteer effect in the
prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Epi-
demiol., 165, 874–881.
Received October 27, 2010; revised March 17, 2011; accepted March 25, 2011
DNA repair gene and colorectal adenoma